Capture patient data direct from source with Reportum
August 12, 2024
A complete picture of drug safety cannot be created if only part of the available data is captured, however the current adverse event capture process
A complete picture of drug safety cannot be created if only part of the available data is captured, however the current adverse event capture process
Through the input of industry leader members of the PV Insights Network, Qinecsa focuses on providing solutions to the safety challenges facing small pharmaceutical and
A top 10 pharma company faced challenges in standardizing safety surveillance across Pharma, Vaccine, and Consumer Health units, including consolidating signal teams, facilitating a divestment,
In her latest article for IPI, Qinecsa President, Humaira Qureshi discussed the practical challenges of integrating medical devices into pharmacovigilance portfolios, the obligations of device
A head of our first exhibition at the DIA Global Annual Meeting, taking place in San Diego from June 16th-20th, Qinecsa spoke with Outsourcing-Pharma about our
Following her attendance at DIA Europe 2024, Humaira Qureshi, President of Qinecsa Solutions, spoke with PharmaPhorum about the transforming pharmacovigilance landscape, the potential barriers and
Drug safety is critical to protect patients and consumers exposed to pharmaceutical development and commercialized drugs. Although the principal framework for Drug Safety and PV
Drug safety leaders speak There are thousands of small pharma and biotech companies around the world. Yet when it comes to drug safety, these organizations
Qinecsa specializes in technology-led, end-to-end pharmacovigilance solutions, built on over 20 years of heritage expertise. As a trusted global partner, we combine best-in-class technology with
Reportum is a unified adverse event platform managing both digital and analogue intake from all sources. It offers a digital-first experience for consumers and healthcare
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274
